DCS’2’s next on chopping block

Discussion in 'Novo Nordisk' started by anonymous, Jan 17, 2019 at 9:09 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    IBM did this for years. It doesn’t work.
     

  2. anonymous

    anonymous Guest

    Actually, IBM fired the bottom 10% of the company every year...and it DID work for quite some time. Regardless, if you want to try and justify how failing to hit your sales goals and finishing in the bottom 20% is having a good year, then have at it. You’re in sales, not working for a charity. Go ahead...tell me how great your year was.
     
  3. anonymous

    anonymous Guest

    It was a disaster and IBM suffered immensely.
     
  4. anonymous

    anonymous Guest

    Didn’t IBM grow $300 billion in value under Jack Welch? Just saying - it might have been bad for morale, but it was good for business. And I think that’s the point here. NNI doesn’t care about morale right now. They want results, and weeding out the bottom is one way to get them.
     
  5. anonymous

    anonymous Guest

    Productivity declined immensely - growth numbers were good but could have been much better.

    It’s like Novo in the early 2000s - it didn’t matter what they did, they were successful. That’s why we have so many incompetents in leadership now - promoted those who weren’t deserving in the explosive decade and now when we need real leadership, it is found wanting.
     
  6. anonymous

    anonymous Guest

    ACTUALLY, Einstein... You can HIT your sales goal and STILL be in the bottom 10% or your district! I've seen it happen! The ENTIRE DISTRICT met their goals! You're STILL always going to have a "BOTTOM 10%." What do you do, THEN?!
     
  7. anonymous

    anonymous Guest

    Back that up with evidence. It’s a fact that IBM grew by $300 billion under Jack Welch’s leadership. Your response is simply your opinion.

    How much did productivity decline? How much better could growth have been?

    You might not like what Novo is doing right now, but that doesn’t make it wrong. Especially considering everyone knows the salesforce is already too big. The best people to cut are the ones who don’t perform.
     
  8. anonymous

    anonymous Guest

    You could always type in more capital letters.

    But, no one cares about the District level. It’s at the Regional level, and the bottom 20% aren’t meeting their goals....in any Region. Are you following me, or is that math too complicated? Being I’m Einstein, I’m pretty smart, and dolts like you might be struggling to understand.
     
  9. anonymous

    anonymous Guest

    There’s a reason why Merck’s not coming to market with it’s insulin. Generic insulin is just around the corner
     
  10. anonymous

    anonymous Guest

    so "splain this" genius. What happened with more than 50% of the country not making goals in POA 1 2018?
     
  11. anonymous

    anonymous Guest

    Bang on! Clowns on stage, a broadcast to rooms when you all are at the same Hotel, in the same city. It makes many cringe to see these jokers promoted to ACL’s. Treating ppl like sh#t. And they expect to motivate?
     
  12. anonymous

    anonymous Guest

    What’s your point? There’s still a bottom 20%, right? And they didn’t hit goal, did they?
     
  13. anonymous

    anonymous Guest

    the company meeting definitely pointed towards a no need for the insulin sales force
     
  14. anonymous

    anonymous Guest

    Agreed!! I could see some of the 2’s becoming overlay reps focusing on high potential basal targets. With GLP-1 growth we certainly do not need a rep focusing on insulin, the NBRX just isn’t there for our territory.
     
  15. anonymous

    anonymous Guest

    Just look at the ozrmpic playing cards they sent us! WTF we get ozrmpic playing cards but can't get copay cards for tresiba? Tell me priorities aren't fucked up!
     
  16. anonymous

    anonymous Guest

    Announcement in August, layoffs in October
     
  17. anonymous

    anonymous Guest

    I don't doubt it. Just wish it was sooner.
     
  18. anonymous

    anonymous Guest

    The executive team meets the week of 3/4/19. Let the rumors begin!
     
  19. anonymous

    anonymous Guest

    Hey dummies, think a little bit beyond how you are going to fit all those Panera bags into your minivan tomorrow without taking out your car seats. We will keep our current numbers to launch oral sema. It has literally been announced from stage that we are “right sized” for the next product to come to market. Once that is done, no need to promote insulin. It is a low profit product will be driven via contracts (read the sales aids mailed to you - greater than 85% coverage). Then the “account management mindset” will be instituted where shared voice will give way to smaller, strategic, sales teams focused on one molecule in two forms.
     
  20. anonymous

    anonymous Guest

    Dave Moore specifically stated NO layoffs beginning of last year, and what happened? They want the employees to remain focused with the "right-sized" speech. I am 100 percent certain there will be lay-offs this year.